GlaxoSmithKline has supported the Cancer Research Institute across patient education and thought leadership, providing sponsorship for the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, inaugural Immunotherapy Patient Summit, and multi-year sponsorship of the Immunotherapy Patient Summit series. In addition, GSK has provided unrestricted support to advance the Cancer Research Institute mission.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
This July for Sarcoma Awareness Month, we look at new research, new treatments, and how we’re working toward a future immune to sarcoma.
CRI-Chordoma Foundation CLIP Investigator Dr. Cassian Yee is exploring how to design cell therapies for patients with a rare type of sarcoma.